Avecho Biotechnology Limited (OEZ) - Cash Flow Conversion Efficiency

Latest as of December 2022: -0.334x

Based on the latest financial reports, Avecho Biotechnology Limited (OEZ) has a cash flow conversion efficiency ratio of -0.334x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-808.80K ≈ $-945.58K USD) by net assets (€2.42 Million ≈ $2.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Avecho Biotechnology Limited to measure how many days the company can operate on defensive assets alone.

Avecho Biotechnology Limited - Cash Flow Conversion Efficiency Trend (2013–2022)

This chart illustrates how Avecho Biotechnology Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Avecho Biotechnology Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avecho Biotechnology Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Country Group Development Public Company Limited BK:CGD	-0.015x
Iz Hayvancilik Tarim ve Gida Sanayi Ticaret AS IS:IZINV	-0.336x
Woojin Plaimm KO:049800	0.110x
Renta Corporacion Real Estate SA MC:REN	0.248x
TBH Global Co Ltd KO:084870	0.170x
rYojbaba Co., Ltd. Common Shares NASDAQ:RYOJ	0.000x
Ashley Services Group Ltd AU:ASH	0.022x
Galil Capital Re Spain SOCIMI SA MC:YGCS	-0.034x

Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Limited (2013–2022)

The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Limited from 2013 to 2022. For the full company profile with market capitalisation and key ratios, see OEZ market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€2.42 Million ≈ $2.83 Million	€-1.67 Million ≈ $-1.95 Million	-0.687x	-0.54%
2021-12-31	€4.54 Million ≈ $5.30 Million	€-3.10 Million ≈ $-3.62 Million	-0.683x	-27.33%
2020-12-31	€2.65 Million ≈ $3.10 Million	€-1.42 Million ≈ $-1.66 Million	-0.536x	-316.76%
2019-12-31	€4.76 Million ≈ $5.56 Million	€1.18 Million ≈ $1.38 Million	0.247x	+144.12%
2018-12-31	€3.90 Million ≈ $4.56 Million	€-2.19 Million ≈ $-2.56 Million	-0.561x	+44.06%
2017-12-31	€6.40 Million ≈ $7.49 Million	€-6.42 Million ≈ $-7.51 Million	-1.003x	-82.13%
2016-12-31	€11.65 Million ≈ $13.62 Million	€-6.41 Million ≈ $-7.50 Million	-0.551x	-82.96%
2015-12-31	€28.93 Million ≈ $33.82 Million	€-8.71 Million ≈ $-10.18 Million	-0.301x	-118.93%
2014-12-31	€49.03 Million ≈ $57.32 Million	€-6.74 Million ≈ $-7.88 Million	-0.137x	+36.70%
2013-12-31	€39.50 Million ≈ $46.18 Million	€-8.58 Million ≈ $-10.03 Million	-0.217x	--

About Avecho Biotechnology Limited

F:OEZ Germany Biotechnology

Market Cap

$30.12 Million

€25.76 Million EUR

Market Cap Rank

#24311 Global

#2108 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.01

All Time High

€0.03